Related Experiment Video
Updated: Jun 18, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Optimizing Patient Engagement in Treatment for Opioid Use Disorder: Primary Care Team Perspectives on Influencing
Elizabeth J Austin1,2, Jessica Chen3, Elena Soyer3
1Department of Health Systems and Population Health, School of Public Health, University of Washington, Box 351621, Seattle, WA, USA. austie@uw.edu.
Background:
Opioid use disorder (OUD) care engagement rates in primary care (PC) settings are often low. Little is known about PC team experiences when delivering OUD treatment and potential factors that influence their capacity to engage patients in treatment. Exploring PC team experiences may inform needed supports that can optimize OUD care delivery and improve outcomes for patients with OUD.
Objective:
We explored multidisciplinary PC team perspectives on barriers and facilitators to engaging patients in OUD treatment.
Design:
Qualitative study using in-depth interviews.
Participants:
Primary care clinical teams.
Approach:
We conducted semi-structured interviews (n = 35) with PC team members involved in OUD care delivery, recruited using a combination of criterion and maximal variation sampling. Data collection and analysis were informed by existing theoretical literature about patient engagement, specifically that patient engagement is influenced by factors across individual (patient, provider), interpersonal (patient-provider), and health system domains. Interviews were professionally transcribed and doubled-coded using a coding schema based on the interview guide while allowing for emergent codes. Coding was iteratively reviewed using a constant comparison approach to identify themes and verified with participants and the full study team.
Key Results:
Analysis identified five themes that impact PC team ability to engage patients effectively, including limited patient contact (e.g., phone, text) in between visits, varying levels of provider confidence to navigate OUD treatment discussions, structural factors (e.g., schedules, productivity goals) that limited provider time, the role of team-based approaches in lessening discouragement and feelings of burnout, and lack of shared organizational vision for reducing harms from OUD.
Conclusions:
While the capacity of PC teams to engage patients in OUD care is influenced across multiple levels, some of the most promising opportunities may involve addressing system-level factors that limit PC team time and collaboration and promoting organizational alignment on goals for OUD treatment.
Related Concept Videos
Patient-centered Care
Drug Therapy
Antianxiety Medications
Analgesia and Pain Management
Methods of Documentation II: POMR
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

